Krystal Biotech announced on Friday that Vyjuvek had been approved by the FDA to treat a rare skin disorder. The company said it plans to launch the gene therapy by the third quarter. Krystal also ...
When I was notified that I was named a rising star, I was shocked! I am very grateful for my team and this recognition from my manager, Britt Liotta, and STN.” — Krystal Tenace, General Manager, ...
Shares of Krystal Biotech (NASDAQ: KRYS) were up more than 15% Monday morning. The company announced on Friday that it had received Food and Drug Administration (FDA) approval for Vyjuvek (beremagene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback